AlzeCure Pharma: AlzeCure Presents its Project Portfolio in Alzheimer's and Pain at Redeye's Theme Day on October 12
STOCKHOLM, SWEDEN / ACCESSWIRE / October 6, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule
Alzecure Pharma Redeye Theme Nasdaq First North Premier Growth Market Nerve Growth Factor Brain Derived Neurotrophic Factor Big Pharma
Source: finanznachrichten.de